Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001908846 | SCV002171342 | uncertain significance | Autosomal recessive DOPA responsive dystonia | 2022-01-15 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 404 of the TH protein (p.Thr404Met). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with TH-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TH protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Laboratory Cellgenetics, |
RCV001908846 | SCV003804497 | likely pathogenic | Autosomal recessive DOPA responsive dystonia | criteria provided, single submitter | clinical testing | The following ACMG criteria were applied in classifying this variant: PM1, PM2, PP2, PP3, PP4. This variant was detected in compound heterozygous state with c.605G>A (p.Arg202His) variant. | |
Ce |
RCV004598159 | SCV005092645 | uncertain significance | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TH: PM2, PM3, PP3 |